Human herpesvirus (HHV) type 8 bas been detectedin both classical and AIDS-related Kaposi's slU'C01Dll, body-cavity lymphomas, and other types of tumors. HHV-8 bas also been detected in DNA from peripheral blood mononuclear cells (PBMC) of some Kaposi's sarcoma patients and more readily in Bcellfractions derivedfrom pllllDed cellsubpopu1at1ons. TwopatientswerefoUowed usingseveral methods: in situhybridization, solutton-based polymerase chain reaction (PeR), and in situ PCR. HHV-8was Intermittently detectedIn Plasma.and detectioncorrelated with detection In PBMC. In situ PCR demonstrated HHV-8 sequences in both peripheral blood B lymphocytes and, to a lesser extent,T lymphocytes. HHV-8 mayundergo periodsof viremia whileat other times It Is undetectable and Infects clrculatlngB cells andsomeT celli.
Nucleic acid sequences of Kaposi's sarcoma (KS)-associ&ted herpesvirus or human herpesvirus (HHV) type 8 have been detected in bothclassical andAIDS-related forms of KS, lymphoma, Castleman's disease, and skin cancers from organ allogra:ft recipients [1] [2] [3] [4] . These sequences were alsofound in DNA extracted from the peripheral blood mononuclear cells (PBMC) ofsome KS patients [5, 6] . Detection ofHHV-8 sequences in PBMC of human immunodeficiency virus (HIV) type I-seropositive persons also comlates with an inc.teased risk of development of KS [5] . Preliminary that the target cells in PBMC could be B lymphocytes [6] . HHV-8wasalsodetected in episomal fonninB celllymphoma cell lines by in situ hybridization [7] , and more recently, in microvascular endothelial cells (MVEC) and spindle cells from KS lesions by in situpolymerase chain reaction (IS-PCR) [8] . We describe 2 patients, followed longitudinally, in whom HHV-8 was detected in tumor tissues, T and B lymphocyte fractions, and cell-free plasma.
Materials and Methods
Patients. Twopatients,1 with AIDS-associated KS and 1 with posttransplant KS, were followed longitudinally.
Patient A was a 34-year-old man with AIDS (CDC stage IV) who presented with visceromegaly, diffuse adenopathy, and an elevated lactate dehydrogenase of 1100 U/dL. A lymph node biopsy revealed KS mixed with areas consistent with angioimmunoblastic lymphadenopathy. The patient was treatedwith intravenous foscarnet for 2 weeks, resulting in gradualdiminution of his tumor and normalization of his lactate dehydrogenase level [9] .
After discontinuation of foscamet, his tumor slowly reappeared.. The patient's sen:un was tested for the presence of Epstein-Barr virus (BBV) antibody and was negative. In addition, the PBMC were also tested for EBV gene sequences by PCR (HCLF-i, immediate-early gene) and shown to be negative (not shown).
Patient B was a 49-year-old Hlv-Iv-scronegative man who had had a renal transplant 7 years earlier for end-stage renal disease. He was taking immunosuppressive drugs (cyclosporine, azathioprine, and prednisone) and, 3 years after transplant, developed lower-extremity cutaneous lesions, which proved to be KS on biopsy. Reduction in the immunosuppressive therapy resulted in slight improvement of his tumor. The patient's PBMC were negative by PCR for EBV gene sequences.
Solution-based PCR. DNA was extracted from PBMC (1-2 X 10 6 ) , and tissue biopsies and PCR were done. DNA (500 ng) was amplified by HHV-8-specific primers (5'-AGCCGAAAG-GATTCCACCATT-3' and Y-TCCGTGTTGTCTACGTCCAGA-3'), using published conditions [10] and analyzed on 1% agarose/ ethidium-bromide gels. The predicted size ofthe specific amplified band was 233 bp (nt 987 -1219 of the published HHV-8 sequence) [10] . To prepare a cell-free virus pellet, plasma was centrifuged at 1800 rpm for 15 min to remove cells and further centrifuged at 3500 rpm for 20 min to remove debris. To pellet virus particles, 5 mL of cell-free plasma was centrifuged at 20,000 rpm using a SW41 Beckman rotor at 4°C for 2 h [11], and pelleted material was resuspended in PBS. The pellets were treated with DNase at 37°C for 30 min (another aliquot was untreated) to rule out possible contamination by infected cellular DNA. This treatment was effective, as it removed any exogenous viral plasmid DNA spiked into a control serum. DNA from the pelleted viruses was then extracted by phenol, followed by ethanol precipitation.
In situ PCR and hybridization. isolated PBMC or subsets (T and B lymphocytes) from both patients were transferred to salinated slides containing a 20-111111 single well. The cells were air-dried overnight, dipped in absolute methanol for 5 min, and then washed twice in IX PBS (Ca~+-and Mg-T-free). Appropriate concentrations of fluorescein isothiocyanate -conjugated monoclonal antibodies directed against T and B cell epitopes, anti-CD3 and anti-CD I 9, respectively, were applied separately to each individual slide. After a I-h incubation at 37°C, the slides were heat-fixed at 105°C for lOs and then incubated in 4% paraforrnaldehyde for 2 h. Paraformaldehyde was inactivated by incubating slides in 3x PBS for 10 min; the slides were then washed twice in I X PBS, for 10 min per wash. These slides were incubated overnight in 0.03% freshly prepared hydrogen peroxide in 1X PBS, to quench the endogenous peroxidase activity. These slides were treated with proteinase K (6 ,ug/mL) at room temperature for 12 min. Proteinase K was inactivated incubating slides on a heat block at 95°C for 5 min. The HHV-8 DNA was amplified in situ with primers that anneal to nt 987-1006 and 1200-1219 [10] . Amplified DNA signals were detected a biotinylated probe, which anneals at nt 1078-I 102 within the amplicons. In situ hybridization was done at 37°C, using a reaction mixture containing 20 pmol of probe, 50% deionized formamide, 2x SSC (1X standard saline citrate = 0.15 MNaCI, 0.015 M sodium citrate), lOX Denhardt's solution, I mg/mL ssDNA, and 0.1% SDS. Amplified DNA was detected using strepavidin-peroxidase; subsequent color was developed using 3-amino 9-ethylcarbazole, and counterstaining was done with Gill's hematoxylin [12, 13] . The percentage of HHV-8-positive cells was determined by counting at least 10,000 cells/slide by 2 independent observers. All microscopic analyses were done on coded slides. NOTE. Cell-free plasma was ultracentrifuged, and pelleted material was tested forpresence ofHHV-8sequences. PCR was done at selected time points. when material was available. PBMC, peripheral blood mononuclear cells.
PBMC were separated with immunomagnetic beads coated with high-affinity monoclonal antibodies (Immunotech, Westbrook, MA) into T and B lymphocyte fractions, using the manufacturer's suggested protocol. Fluorescence-activated cell sorting analysis of the Band T cell fractions demonstrated 95% purity by CD 19 and CD3 positivity, respectively. PBMC of patient B were also separated by this technique into Band T cell fractions and found to be 99.5% pure B or T cells. For positive internal controls, the conserved region ofHLA-DQAI, using primers HLA-DQ-GH26-27 (Synthetic Genetics, San Diego), was amplified (not shown). Negative controls for each assay were PBMC from HHV-8-ncgative, HIV-L-seronegative persons. Positive controls contained a mixture of an HHV-8-infected MVEC developed in our laboratory (data not shown) mixed with an HHV-8-negative MVEC cell line containing 10% HHV-8-positive cells. Additional negative controls involved the use of irrelevant primers and unrelated probes (e.g., EBV-and cytomegalovirus-specific), as previously reported [11, 12] .
Results

Fluctuation in HHV-8 viremia determined by PCR analyses.
Seven blood samples were taken from patient A over 3 months, and 4 were taken from patient B over 2 months (table I) . PCR was done on both patients' original tumor biopsies, PBMC, and pelleted plasma (table I). Both tumor biopsies were positive by PCR. PBMC from patient A were positive for HHV-8 at the first time point but only weakly positive at the second (table  1) . PCR signals were not detected at time points 3 and 4 but were at the next several time points (table 1). The negative and positive samples were detected by Southern blot hvbridization, by sta ndar d in situ hybridization in the 2 patients (0.8% -0.3% ; data not sho wn). Signals were localized near the nuc lear membrane w ithin the cytoplasm. consistent with the ep isomal nature of thi s virus , as previously described [7] .
To determine which subpopulation of monon uclear cells ha rbor HH V-8. PBM C from patient A were first separated with immunomagnetic bead s into T and B lymph ocyte fraction s, and PCR was done on extracted DNA from cac h frac tion (table  1) . HHV -8 signa ls were repeat ed ly detected (patient A: time po ints 6 and 7) in th e B cell fraction; the corresp onding T ce ll fraction was wea kly positi ve (data not shown). This resu lt supports recent findings of Ambroziac et al. [6] that I-1J-l V-8 signa ls are detected main ly in the B cell fraction. However, when T and B lymphocyte fractions were analyzed by highl y sensi tive IS-PCR, in w hich a sing le copy of a gene or frag ment of a gene can be amp lified in situ [12, 13] , some T cells were also positive , althoug h significantly less (range, 1.2% -2.2% in pa tient A and 0.1 % -0.9% in patient B) than in the B ce ll fraction (range, 39%-48 % in patient A and 27% -33% in patient E) ( figure 2C, D) .
using the labeled 233 -bp frag me nt as a probe. The detecti on of HHV -8 also correlated wit h relapse an d progression of patient A ' s tum or. Of note , the negative samples were drawn during foscarnet treatment. PBMC from pati ent B we re posi tive for HH V-8 sequences in itiall y bu t su bsequently became negative (table I) . During this per iod, no trea tme nt was given, and there was no change in his clini cal status .
In order to study whether a cell-free phase of HH V-8 ex ists, solution-based PCR was don e directly on plasma samples at diffe rent time points. Initially, HH V-8 signals were not detectable in the plas ma . To increase sensitivity and minimize detection of contaminating cellular DNA, the viru s pa rticles w ere pe lleted by high -spe ed centri fugation and treated with DNa se before DN A extraction and PCR analys is . Strong pos itive signals were detected in the DNA extracted (30 ng) from the pe lleted virus treated with DN ase, as demonstrated by ethidium-brornide gels and by Southern blot analysis of the same gels, using a rad iolabe led 330 Bam probe (figure lA, E , res pectively) . As shown in table 1, HHV -8 sig nals were detecte d in both tre ated and untreated samp les from patient A (tim e p oints 1, 5, and 7) and patie nt B (time poi nt 1). PCR resu lts were negative at other time points (patient A: time points 3 and 4; patie nt B : time point 2 and later), when PBMC were also negative .
Detection and localization ofHHV-8 ill PBMC subsets. To determine the cell type harboring HHV -8, in situ hybridization and IS-PCR we re done. HH V-8 signa ls were found , by IS-PCR , in 20 % -30% of the PBM C from patient A and 11% -23% of tho se from patient E ( figure 2A , B, respective ly) . No such sign als we re detected in norm al control PBMC fro m a disease -free HIV-I -seronegative person (data not shown) . There were relatively fewer HHV-8-positive PBMC detected Di sc ussion Until now , ev idence of H HV -8 sequences in peri pheral blood ce lls from KS patients has been bas ed on PCR or DNA extracted from mononuclear cells. We detected HH V-8 signals by an in situ PCR method in PBMe. Althoug h PCR anal ysi s of pa nned lymphocyte popu lations detected signa ls in only the B cell frac tion, we dem onstrated that HH V-8 has a broader tropi sm and can infect T lym phocytes. 1t is possible that the HHV -8-positive cells containe d in the T cell fraction were contaminatin g B cells. However, by combining an immunohistoc hemi stry assay with in situ PCR [ 12, 13] . we confirmed that sma ll percentage s of T cells were indeed infected with HH V-8 in the PBMC of both our patients. Detection of this se que nce in B cells is consis tent with a recent report of HHV-8-positi ve B lymphoma cell lines deri ved from body-cavity -associated lym phomas in AIDS patients [7] . Und er circumstances of severe immunosuppression, infection by I-I1-:rV-8 ma y directly or indirectly contribute to tra nsformation of B cells. The dire ct role of HHV-8 in the development of bod y-cavity lymphom as is complicated by the coinfection of th ese cells by EBV. Detection of HHV-8 in plasma from DN ase-treated and untreated samples suggests that the signa l mu st origin ate from intact virus part icles rath er than from con tam inating infected cellu lar DNA and that HH V-8 has virem ic stages in which cell-free particle s are found in the circulation. Negative PCR resu lts from both fractions (plasma and PB MC) at other tim e points ind icate that HHV-8 may also go through periods of latency, when it is extremely diffic ult to detect by PCR.
The host ra ng e for HHV-8 has not been clearl y defin ed. A recent stud y has dem onst rat ed that th e spi nd le and MVE C of the KS le sion s are po sit ive fo r HH V -8 se que nces by ISpeR [8] . W e have also fo und infection of M VEC, spi ndle l ID 1996; 174 (Novem ber) cell s, and various layers of dermis in the tissues of all thre e major types of KS (i.e., classic al, Afri can endemi c, and AIDS-asso ciated; unpubli shed data). The data in this report support the contention that HH V -8 is a unique viral agent able to infect PBMC with an intermittent viremic phase. There may be a primary infecti on of mononuclear cells, followed by infection of MVEC or transient viremia and active replication of the virus from latent site(s) during immunosuppression. Our findings that infection of PBM C by HEV-8 may be cyclical could also explain why this agent cannot consistentl y be detected within PBMC in all KS patients [5] . It will be important to study a larger longitudinal panel of patients to determine the relationship between HHV -8 viremia, clini cal status, and progression to the development of Kaposi ' s sarcoma.
